HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mahdi Ghadi Selected Research

N-(3-pyridylmethyl)adriamycin (YM 1)

4/2021Data on the in vitro and in vivo anti-tumor effects of itraconazole, paclitaxel, and the two in combination in HT-29 and YM-1 cancer cell line and HT-29 colon cancer xenograft models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mahdi Ghadi Research Topics

Disease

2Colonic Neoplasms (Colon Cancer)
04/2021 - 03/2021
2Neoplasms (Cancer)
04/2021 - 03/2021
1Colorectal Neoplasms (Colorectal Cancer)
03/2021

Drug/Important Bio-Agent (IBA)

2Itraconazole (Sporanox)FDA LinkGeneric
04/2021 - 03/2021
2Therapeutic UsesIBA
04/2021 - 03/2021
2Paclitaxel (Taxol)FDA LinkGeneric
04/2021 - 03/2021
1N-(3-pyridylmethyl)adriamycin (YM 1)IBA
04/2021
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
03/2021

Therapy/Procedure

2Drug Therapy (Chemotherapy)
04/2021 - 03/2021